You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
18 April 2024
PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023
14 March 2023
PharmaSGP Holding SE releases forecast for full year 2023
3 January 2023
PharmaSGP Holding SE resolves on buyback program for own shares of up to 1.5 million Euro
10 November 2022
PharmaSGP Holding SE raises forecast for FY 2022
15 September 2021
PharmaSGP Holding SE raises forecast for FY 2021 following completion of acquisition of OTC brand portfolio
15 June 2021
PharmaSGP Group acquires OTC brand portfolio (Baldriparan, Formigran, Spalt and Kamol) from GSK